Wednesday's ETF Movers: RSSL, RODM
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 25 2025
0mins
Source: NASDAQ.COM
ETF Performance: The Hartford Multifactor Developed Markets ETF is underperforming, down approximately 2.4% in Wednesday afternoon trading, with GSK and GIB shares each declining by about 1.3%.
Author's Perspective: The opinions expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
Analyst Views on RSSL
Wall Street analysts forecast RSSL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RSSL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 104.980
Low
Averages
High
Current: 104.980
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
